|
MRNA's Net Income Growth by Quarter and Year
Moderna Inc 's Net Income results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
MRNA Net Income (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
IV Quarter |
December |
1,465.00
|
4,868.00
|
-272.49
|
-4.08
|
III Quarter |
September |
1,043.00
|
3,333.00
|
-233.64
|
-2.56
|
II Quarter |
June |
2,197.00
|
2,780.00
|
-116.71
|
-2.78
|
I Quarter |
March |
3,657.00
|
1,221.00
|
-124.23
|
-2.56
|
FY |
|
8,362.00
|
12,202.00
|
-747.07
|
-11.98
|
MRNA Net Income fourth quarter 2022 Y/Y Growth Comment |
Moderna Inc reported drop in Net Income in the fourth quarter 2022 by -69.91% to $ 1,465.00 millions, from the same quarter in 2021. The fall in the fourth quarter 2022 Moderna Inc 's Net Income compares unfavorably to the Company's average Net Income doubling of 498.79%.
Among companies who have reported fourth quarter 2022 results in the Biotechnology & Pharmaceuticals industry only one Company has achieved higher year on year Net Income results in the fourth quarter 2022. While Moderna Inc ' s Net Income meltdown of -69.91% ranks overall at the positon no. 82 in the fourth quarter 2022.
|
MRNA Net Income ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
December |
-69.91 % |
- |
- |
- |
III Quarter |
September |
-68.71 % |
- |
- |
- |
II Quarter |
June |
-20.97 % |
- |
- |
- |
I Quarter |
March |
199.51 % |
- |
- |
- |
FY |
|
-31.47 % |
- |
- |
- |
MRNA Net Income (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
December |
40.46 % |
46.05 % |
- |
- |
III Quarter |
September |
-52.53 % |
19.89 % |
- |
- |
II Quarter |
June |
-39.92 % |
127.68 % |
- |
- |
I Quarter |
March |
-24.88 % |
- |
- |
- |
FY (Year on Year) |
|
-31.47 % |
- |
- |
- |
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
2347.15 % |
498.79 % |
-190.51 % |
(Mar 31 2022) |
|
(Mar 31 2017) |
|
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
2347.15 % |
498.79 % |
-190.51 % |
(Mar 31 2022) |
|
(Mar 31 2017) |
|
Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Moderna Inc 's Q/Q Net Income Growth
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
127.68 % |
16.19 % |
-89.24 % |
(Jun 30 2021) |
|
|
MRNA's IV. Quarter Q/Q Net Income Comment |
Moderna Inc achieved in the IV. Quarter 2022 above company average sequential Net Income jump of 40.46%, to $ 1,465.00 millions, from $1,043.00 millions in the third quarter.
Within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Net Income quarter on quarter growth. While Moderna Inc 's Net Income growth quarter on quarter, overall rank is 479. |
|
|
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
127.68 % |
16.19 % |
-89.24 % |
(Jun 30 2021) |
|
|
MRNA's IV. Quarter Q/Q Net Income Comment |
Moderna Inc achieved in the IV. Quarter 2022 above company average sequential Net Income jump of 40.46%, to $ 1,465.00 millions, from $1,043.00 millions in the third quarter.
Within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Net Income quarter on quarter growth. While Moderna Inc 's Net Income growth quarter on quarter, overall rank is 479. |
|
Moderna Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending (Dec 31 2022) |
12 Months Ending (Sep 30 2022) |
12 Months Ending (Jun 30 2022) |
12 Months Ending (Mar 31 2022) |
12 Months Ending (Dec 31 2021) |
Cumulative Net Income 12 Months Ending |
$ 8,362.00 |
$ 11,765.00 |
$ 14,055.00 |
$ 14,638.00 |
$ 12,202.00 |
Y / Y Net Income Growth (TTM) |
-31.47 % |
66.61 % |
302.16 % |
2347.15 % |
- |
Year on Year Net Income Growth Overall
Ranking |
# 1702 |
# 2203 |
# 2134 |
# 2019 |
# 2019 |
Seqeuential Net Income Change (TTM) |
-28.92 % |
-16.29 % |
-3.98 % |
19.96 % |
72.8 % |
Seq. Net Income Growth (TTM) Overall
Ranking |
# 82 |
# 42 |
# 60 |
# 557 |
# 0 |
Cumulative Net Income growth
Comment |
For the 12 months ended Dec 31 2022 Moderna Inc reported a drop in Net Income by -31.47% year on year, to $8,362 millions, compare to the 66.61% growth at Sep 30 2022.
Looking into Healthcare sector trailing twelve month Net Income increase, only one company had higher growth. While Total ranking has impoved so far to 1702, from total ranking in previous quarter at 2203. |
Net Income TTM Q/Q Growth Statistics |
High |
Average |
Low |
2347.15 % |
498.79 % |
-190.51 % |
|
|
|
|
|
Net Income TTM Y/Y Growth Statistics |
High |
Average |
Low |
2347.15 % |
227.71 % |
-190.51 % |
(Mar 31 2022) |
|
|
Net Income TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 2 |
Sector |
# 6 |
S&P 500 |
# 82 |
|
Cumulative Net Income growth
Comment |
For the 12 months ended Dec 31 2022 Moderna Inc reported a drop in Net Income by -31.47% year on year, to $8,362 millions, compare to the 66.61% growth at Sep 30 2022.
Looking into Healthcare sector trailing twelve month Net Income increase, only one company had higher growth. While Total ranking has impoved so far to 1702, from total ranking in previous quarter at 2203. |
Net Income TTM Q/Q Growth Statistics |
High |
Average |
Low |
2347.15 % |
498.79 % |
-190.51 % |
|
|
|
Net Income TTM Y/Y Growth Statistics |
High |
Average |
Low |
2347.15 % |
227.71 % |
-190.51 % |
(Mar 31 2022) |
|
|
Net Income TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 2 |
Sector |
# 6 |
S&P 500 |
# 82 |
|